Cardinal Health (CAH) has been garnering attention recently with a multitude of favorable events. Wells Fargo raised their outlook on the company, pointing to its broad business strengths and resilience. The board of directors has approved a quarterly dividend. Shareholders may experience notable returns given the record trading levels of CAH stocks which even reached a fresh all-time high. Moreover, NEOS Investment Management LLC expressed its trust and confidence in CAH by purchasing a substantial amount of their shares, adding to the positive momentum supported by multiple positive earnings reports. Nevertheless, despite raising profit outlook supported by specialty strength and capital returns, CAH's shares were briefly down by 5.3%. However, with its latest 12.23% upside potential and steady specialty and pharma units amplified further by their plans for pharmaceutical distribution network expansion, Cardinal Health depicts robust share price gains that are deemed attractive by the investment community.
Cardinal Health CAH News Analytics from Thu, 12 Jun 2025 07:00:00 GMT to Fri, 20 Feb 2026 23:13:59 GMT -
Innovation 5
- Rumor 7
